Celsion to Present at the 14th Annual BIO CEO & Investor Conference
(firmenpresse) - LAWRENCEVILLE, NJ -- (Marketwire) -- 02/06/12 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that Michael H. Tardugno, Celsion's President and Chief Executive Officer, will be presenting at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on Monday, February 13 at 9:00 A.M. Eastern Time at the Waldorf=Astoria Hotel in New York City.
A live webcast of the presentation will be available on Celsion's website at . The webcast will be archived on the same site for replay following the conference.
Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, and the North Shore Long Island Jewish Health System.
For more information on Celsion, visit our website: .
Investor Contact
David Pitts
Argot Partners
212-600-1902
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.02.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 111194
Anzahl Zeichen: 0
contact information:
Town:
LAWRENCEVILLE, NJ
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 189 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Celsion to Present at the 14th Annual BIO CEO & Investor Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Celsion Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
